[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@JusticeforB_MD JusticeforB_MD

JusticeforB_MD posts on X about $aclx, thank you, longterm, soc the most. They currently have XXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

• X Week XXXXX -XX%
• X Month XXXXX +43%
• X Months XXXXXX +424%
• X Year XXXXXX +1,830%

Mentions: X #

• X Month XX -XX%
• X Months XXX +163%
• X Year XXX +1,050%

Followers: XXX #

• X Week XXX +1%
• X Month XXX +6.30%
• X Months XXX +91%
• X Year XXX +306%

CreatorRank: undefined #

Social Influence

Social topic influence $aclx #9, thank you, longterm, soc, $dbvt, milk, $gh, future, $iron, $insm

Top accounts mentioned or mentioned by @monacobiotech @oncinvestor @houndcl @profoak @anexpertone1 @biovalues @pawcio2009 @joshthe3rd @aditharun @fl0wg0d @geneinvesting @seedy19tron @erikotto2 @varroanalytics @tomsilver39 @pharmdca @biopharmiq @bpharmcatalyst @joserestonva @adamfeuerstein

Top assets mentioned Arcellx, Inc. Common Stock (ACLX) Guardant Health, Inc. Common Stock (GH) Disc Medicine, Inc. Common Stock (IRON) Insmed, Inc. (INSM)

Top Social Posts

Top posts by engagements in the last XX hours

"@adamfeuerstein seems like an overreaction. $ACLX is much further along with higher number of patients treated"
X Link 2025-11-24T18:05Z XXX followers, XXX engagements

"@FiercePharma interesting. Should be good news for anito-cel and $ACLX"
X Link 2025-11-13T00:11Z XXX followers, XXX engagements

"@adamfeuerstein interesting. Thank you and appreciate you sharing this Absence of lymphodepletion with KLN-1010 is promising though wonder about long-term risk with viral vector. I still see anito-cel by $ACLX advancing SOC"
X Link 2025-11-24T18:44Z XXX followers, XXX engagements

"$DBVT with pending data for P3 in the VITESSE trial this quarter. Think use of a peanut patch for desensitization is much safer than either OIT or xolair. Current MC also ignoring promise of cow's milk allergy program"
X Link 2025-11-24T19:12Z XXX followers, 1194 engagements

"@peter_mantas agree. Would also add $GH to #4"
X Link 2025-12-08T18:53Z XXX followers, XXX engagements

"@Banana_Oncology their platform is pretty amazing. Previous good data for IRAK4 degrader as well. Their MC is pretty high but their future is bright"
X Link 2025-12-08T17:58Z XXX followers, XXX engagements

"@BowTiedBiotech than you for bringing attention to $IRON. I expect the data to show DISC-0974 reduces transfusion dependence in MF. Would be a much needed treatment option"
X Link 2025-11-24T23:37Z XXX followers, XXX engagements

"@FL0WG0D $INSM with awesome trajectory overall and pending trial results for brensocatib in sinusitis"
X Link 2025-12-01T19:40Z XXX followers, XXX engagements

"@adamfeuerstein unfortunately this is the right move. If the company is confident in their product they should immediately dose more patients with AMT-130 in an RCT compared to SoC. I don't think that's unreasonable"
X Link 2025-12-04T18:31Z XXX followers, XXX engagements

"@Drchik23 this is under-the-radar. And going after unique targets (pre-eclampsia/AIS). Really like the potential on $DMAC and think it'll go much higher though this is more likely 2H'26"
X Link 2025-12-09T00:26Z XXX followers, XXX engagements